首页> 外文期刊>Molecular cytogenetics >Report of a patient and further clinical and molecular characterization of interstitial 4p16.3 microduplication
【24h】

Report of a patient and further clinical and molecular characterization of interstitial 4p16.3 microduplication

机译:间质性4p16.3微复制的患者以及进一步的临床和分子表征的报告

获取原文
获取外文期刊封面目录资料

摘要

Background Pure interstitial duplications of chromosome band 4p16.3 represent an infrequent chromosomal finding with, to the best of our knowledge, only two patients to date reported. Case presentation We report on a 13-year-old boy showing a set of dysmorphic facial features, attention deficit hyperactivity disorders, learning difficulties, speech and cognitive delays, overgrowth and musculoskeletal anomalies in whom an interstitial duplication of about 400 kb in 4p16.3 was detected by SNP-array analysis. The duplication includes the complete coding sequence of FAM53A, SLBP, TMEM129 and TACC3 genes and the first exon of the FGFR3 gene. Phenotypic comparison with previously described patients harboring a microduplication of similar size and position contributes to better define the clinical correlation of 4p16.3 microduplications, suggesting the existence of a novel distinct and phenotypically recognizable syndrome. In addition, being the duplication identified in our case the smallest so far reported, it allowed us to refine the smallest region of overlap among patients to 222 kb, enabling a more accurate genotype-phenotype correlation for 4p16.3 microduplications. Conclusions Our case report provide clinical and molecular evidences supporting the existence of a novel 4p16.3 microduplication syndrome. The genes FAM53A, TACC3 and FGFR3 seems to play a key role in the etiology of the clinical phenotype. Interestingly, our patient is the oldest described so far and for this reason useful to delineate the long-term prognosis of these patients.
机译:背景染色体带4p16.3的纯间质重复表示不常见的染色体发现,据我们所知,迄今为止仅报道了两名患者。病例报告我们报告了一个13岁男孩,该男孩表现出一系列畸形的面部特征,注意力缺陷多动障碍,学习困难,言语和认知迟缓,过度生长和肌肉骨骼异常,其中在4p16.3中间隙重复约400 kb通过SNP-阵列分析检测到。重复序列包括FAM53A,SLBP,TMEM129和TACC3基因的完整编码序列以及FGFR3基因的第一个外显子。表型与先前描述的患者具有相似的大小和位置的微复制的比较有助于更好地定义4p16.3微复制的临床相关性,表明存在一种新颖的,在表型上可识别的综合征。此外,由于在我们的案例中鉴定出的重复序列是迄今为止报道的最小重复序列,它使我们能够将患者之间的最小重叠区域优化为222 kb,从而为4p16.3微复制提供了更为准确的基因型与表型相关性。结论我们的病例报告提供了支持新型4p16.3微复制综合征的临床和分子证据。 FAM53A,TACC3和FGFR3基因似乎在临床表型的病因中起着关键作用。有趣的是,我们的患者是迄今为止描述的最古老的患者,因此可用于描述这些患者的长期预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号